NorthStar Medical Radioisotopes has expanded its strategic collaboration with Curadh, the organization announced today. According to a release, under the new agreement, NorthStar will manufacture and distribute patient doses for…
Cellectar Biosciences has expanded its licensing agreement with the Wisconsin Alumni Research Foundation (WARF) for intellectual property that was the result of collaborative research conducted at the University of Wisconsin…
Exact Sciences has awarded $1.3 million to 23 organizations through its Funding Opportunities for Colorectal Screening Uptake Strategies (FOCUS) Program, the company announced today. According to a release, the FOCUS…
SHINE Technologies and Nucleus RadioPharma are partnering to advance radioligand cancer treatments, SHINE announced recently. “We are proud to partner with Nucleus RadioPharma to supply the high-purity lutetium-177 that powers…
Cellectar Biosciences is partnering with Florida Cancer Specialists & Research Institute (FCS) to advance patient care and further define the U.S. treatment landscape, the company announced today. According to a…
Stem Pharm announced recently that it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to advance a groundbreaking model of Alzheimer’s…
SHINE Technologies has raised $70 million in additional funding to accelerate the commercialization of near-term applications of fusion technology, the company announced today. The round was led by existing investors…
Promega announced today that it is collaborating with GSK, a global biopharma company, to plan, develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit. According to a…
BioForward announced recently the recipients of its ninth annual Wisconsin Biohealth Awards, which recognize exceptional scientific and business accomplishments within the state’s biohealth industry. Dr. Thomas Grist, the chair of…
Exact Sciences announced today that it acquired Resolution Bioscience from Agilent Technologies. According to a release, Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more…
